3 hours Voyager Therapeutics (NASDAQ:VYGR) Coverage Initiated by Analysts at Leerink PartnersMarketBeat
Leerink Partners assumed coverage on Voyager Therapeutics in a research report on Wednesday. They issued an “outperform” rating and a $15.00 target price on the stock.
X